Capasso, Anna
Università degli Studi di Salerno,
Italy
2024 Rank: 134989
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 483 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 134989 | 129418 |
| Total Cites | 2797 | 3440 |
| H-index | 27 | 31 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 279 | 282 |
| Number of Single+First Authored Papers | 106 | 106 |
| Total Cites to Single+First Authored Papers | 935 | 1154 |
| Number of Single+First+Last Authored Papers | 208 | 208 |
| Total Cites to Single+First+Last Authored Papers | 1746 | 1997 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2539 | 2881 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.19 |
| Self-Citation Percentage |
18.69%
|
|
Capasso, Anna
Università degli Studi di Salerno,
Italy
2023 Rank: 137409
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 499 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 137409 | 130984 |
| Total Cites | 2566 | 3195 |
| H-index | 26 | 30 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 256 | 259 |
| Number of Single+First Authored Papers | 106 | 106 |
| Total Cites to Single+First Authored Papers | 896 | 1114 |
| Number of Single+First+Last Authored Papers | 205 | 205 |
| Total Cites to Single+First+Last Authored Papers | 1588 | 1834 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2315 | 2647 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.21 |
| Self-Citation Percentage |
19.69%
|
|
Capasso, Anna
Università degli Studi di Salerno,
Italy
2022 Rank: 140154
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 512 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 140154 | 130952 |
| Total Cites | 2342 | 2948 |
| H-index | 24 | 28 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 223 | 226 |
| Number of Single+First Authored Papers | 106 | 106 |
| Total Cites to Single+First Authored Papers | 844 | 1060 |
| Number of Single+First+Last Authored Papers | 203 | 203 |
| Total Cites to Single+First+Last Authored Papers | 1439 | 1679 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2098 | 2412 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.22 |
| Self-Citation Percentage |
20.56%
|
|
Capasso, Anna
Università di Salerno,
Italy
2020 Rank: 133327
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 639 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133327 | 126874 |
| Total Cites | 2005 | 2551 |
| H-index | 23 | 27 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 185 | 188 |
| Number of Single+First Authored Papers | 106 | 106 |
| Total Cites to Single+First Authored Papers | 749 | 961 |
| Number of Single+First+Last Authored Papers | 185 | 185 |
| Total Cites to Single+First+Last Authored Papers | 1233 | 1466 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1788 | 2068 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.23 |
| Self-Citation Percentage |
21.40%
|
|